ALPEK, S.A.B. de C.V. (FRA:27A)
| Market Cap | 1.29B +23.2% |
| Revenue (ttm) | 5.85B -13.2% |
| Net Income | -195.43M |
| EPS | -0.09 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 33.77 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 0.5950 |
| Previous Close | 0.6000 |
| Day's Range | 0.5950 - 0.5950 |
| 52-Week Range | 0.3620 - 0.6100 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 24, 2026 |
About ALPEK
ALPEK, S.A.B. de C.V., together with its subsidiaries, operates as a petrochemical company in Mexico, the United States, Argentina, Brazil, Chile, Canada, the United Kingdom, Oman, and Saudi Arabia. It operates in two segments, Polyester, and Plastic and Chemicals. The company offers purified terephthalic acid (PTA), an organic compound that is raw material for PET; polyethylene terephthalate (PET), a plastic resin that creates products for their lightness, hygiene, and resistance along with their recyclability; recycled PET for new bottles and... [Read more]
Financial Performance
In 2025, ALPEK's revenue was 126.84 billion, a decrease of -7.69% compared to the previous year's 137.41 billion. Losses were -2.77 billion, 262.6% more than in 2024.
Financial numbers in MXN Financial StatementsNews
Alpek upgraded to Outperform from Sector Perform at Scotiabank
Scotiabank analyst Ben Isaacson upgraded Alpek (ALPKF) to Outperform from Sector Perform with a price target of MXN 15, up from MXN 12.50. The firm sees the company as benefitting…
ALPEK Earnings Call Transcript: Q1 2026
Q1 saw a 50% sequential EBITDA increase, driven by strong execution, asset optimization, and favorable market conditions amid geopolitical disruptions. Guidance for Q2 is robust, with further asset sales and specialty product investments expected to enhance margins.
ALPEK Earnings release: Q1 2026
ALPEK released its Q1 2026 earnings on April 23, 2026, summarizing the period's financial results.
ALPEK Slides: Q1 2026
ALPEK has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 23, 2026.
Alpek downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley downgraded Alpek (ALPKF) to Equal Weight from Overweight with a price target of MXN 10, down from MXN 14. The firm notes that while it continues to like…
ALPEK Earnings Call Transcript: Q4 2025
2025 saw a 30% drop in EBITDA due to overcapacity and weak demand, but free cash flow improved 57%. 2026 guidance projects $450–$500 million EBITDA, with deleveraging and asset sales as top priorities. Market recovery remains uncertain, but strategic growth and cost controls are in focus.
ALPEK Earnings release: Q4 2025
ALPEK released its Q4 2025 earnings on February 11, 2026, summarizing the period's financial results.
ALPEK Slides: Q4 2025
ALPEK has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 11, 2026.
Alpek downgraded to Market Perform from Outperform at BBVA
BBVA downgraded Alpek (ALPKF) to Market Perform from Outperform with a MXN 11.60 price target
ALPEK Earnings Call Transcript: Q3 2025
Sequential EBITDA and cash flow improved, but full-year guidance was revised down due to persistent oversupply, low margins, and heavy imports. Merger approval and new U.S. tariffs on PET are expected to benefit results from 2026.
ALPEK Quarterly report: Q3 2025
ALPEK has published its Q3 2025 quarterly earnings report on October 22, 2025.
ALPEK Slides: Q3 2025
ALPEK has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 22, 2025.
Alpek upgraded to Outperform from Neutral at Grupo Santander
Grupo Santander upgraded Alpek (ALPKF) to Outperform from Neutral with a MXN 15.50 price target
ALPEK Earnings Call Transcript: Q2 2025
Second quarter results showed resilient plastics and chemicals performance offsetting polyester margin pressure from global oversupply and tariffs. Guidance was revised lower, with a focus on cost control, asset optimization, and financial flexibility.
ALPEK Earnings release: Q2 2025
ALPEK released its Q2 2025 earnings on July 23, 2025, summarizing the period's financial results.
ALPEK Slides: Q2 2025
ALPEK has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on July 23, 2025.
ALPEK Earnings Call Transcript: Q1 2025
Faced with global overcapacity and trade uncertainties, margins declined, especially in polyester, while plastics and chemicals remained stable. Asset sales, cost controls, and new business initiatives are key to deleveraging and future growth, with working capital release expected by year-end.
ALPEK Earnings release: Q1 2025
ALPEK released its Q1 2025 earnings on April 23, 2025, summarizing the period's financial results.
ALPEK Slides: Q1 2025
ALPEK has posted slides in relation to its Q1 2025 quarterly earnings report, which was published on April 23, 2025.
Alpek downgraded to Neutral from Outperform at Grupo Santander
Grupo Santander analyst Rodrigo Reis de Almeida downgraded Alpek (ALPKF) to Neutral from Outperform with a MXN 17.50 price target
ALPEK Earnings Call Transcript: Q4 2024
Comparable EBITDA for 2024 exceeded guidance at $699 million, driven by cost-saving initiatives and higher container freight costs. 2025 guidance anticipates lower EBITDA of $625 million due to reduced freight rates, with a focus on further cost reductions and maintaining strong cash flow.
ALPEK Earnings release: Q4 2024
ALPEK released its Q4 2024 earnings on February 19, 2025, summarizing the period's financial results.
ALPEK Slides: Q4 2024
ALPEK has posted slides in relation to its Q4 2024 quarterly earnings report, which was published on February 19, 2025.
Alfa|SIGMA reports Comparable EBITDA of US $1 billion in 2024, with Alpek as Discontinued Operations
SAN PEDRO GARZA GARCÍA, N.L., Mexico , Feb. 18, 2025 /PRNewswire/ -- ALFA, S.A.B.
ALPEK Earnings Call Transcript: Q3 2024
Q3 2024 results exceeded expectations with strong EBITDA, driven by high freight costs and stable demand. Guidance for 2024 EBITDA was raised, CapEx reduced, and leverage is expected to improve further. The spin-off process is progressing, and cost savings initiatives are on track.